FNY Investment Advisers’s Repare Therapeutics RPTX Stock Holding History

FNY Investment Advisers’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,000	Closed	-$91K	–	1045
2025 Q4	$91K	Buy	+35,000	New	+$70.5K	0.03%	352
2020 Q3	–	Sell	-300	Closed	-$9K	–	589
2020 Q2	$9K	Buy	+300	New	+$9.63K	0.01%	286

FNY Investment Advisers's RPTX Position: Q1 2026 in Review

FNY Investment Advisers sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 35,000 shares — an estimated $91K sold.

FNY Investment Advisers first reported a position in RPTX in Q2 2020 and held it in 2 quarters. The position peaked at $91K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

FNY Investment Advisers reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
FNY Investment Advisers sold 35,000 Repare Therapeutics shares in Q1 2026, an estimated $91K.
FNY Investment Advisers first reported a position in Repare Therapeutics in Q2 2020 and held it in 2 quarters.
FNY Investment Advisers's Repare Therapeutics position peaked at $91K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.